Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Phase II
OXiGENE (OXGN) Initiates Phase 2 Study Of Fosbretabulin In Gastrointestinal Neuroendocrine Tumors 9/18/2014 7:42:55 AM
Heat Biologics Commences Patient Dosing In Phase 2 Study Of Viagenpumatucel-L For The Treatment Of Non-Small Cell Lung Cancer 9/18/2014 7:44:29 AM
ProSensa Holding N.V. (RNA) Announces Commencement Of Re-Dosing Of Drisapersen In North America In Patients With Duchenne Muscular Dystrophy 9/18/2014 7:52:30 AM
Rebiotix Release: PUNCH CD Study Drug Targeting Recurrent C. Difficile Infection To Be Presented At IDWeek 2014 9/18/2014 8:01:52 AM
Immune Pharmaceuticals, Inc. Initiates Phase 2 Clinical Trial In Ulcerative Colitis 9/18/2014 8:28:02 AM
Auxilium Pharmaceuticals (AUXL) Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 9/18/2014 8:44:33 AM
Flexion Therapeutics (FLXN) Reports FDA Clinical Hold For Phase 2b Trial Of Osteoarthritis Drug 9/18/2014 6:57:27 AM
SWOG To Resume Clinical Trial Of Halozyme Therapeutics, Inc. (HALO)'s PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 9/18/2014 10:05:54 AM
Galapagos Reports High Participation Rate In Long Term Extension Study With GLPG0634 In RA Patients 9/18/2014 10:27:18 AM
Novavax, Inc. (NVAX) Initiates Phase 2 Clinical Trial Of RSV F-Protein Nanoparticle Vaccine Candidate In Healthy Third-Trimester Pregnant Women 9/17/2014 7:34:27 AM
BioBlast Pharma (ORPN) Announces Preclinical And Clinical Pharmacokinetic Results With Cabaletta, Interim Safety Results From Phase 2/3 HOPEMD Study In OPMD 9/17/2014 7:53:46 AM
Can-Fite BioPharma (CFBI)'s Drug CF101 Is Presented In Scientific Journal As One Of Four Small Molecule Drugs For The Treatment Of Psoriasis 9/17/2014 8:25:29 AM
Neuraltus Pharmaceuticals, Inc.' ALS Treatment Candidate, NP001, Highlighted At ALS Research Group Summit 9/17/2014 8:41:55 AM
Glenmark Pharmaceuticals's TRPA1 Antagonist 'GRC 17536' Shows Positive Data In A Proof Of Concept Study 9/17/2014 9:34:26 AM
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Successful Results For MOB-015 In A Phase II Study For The Treatment Of Onychomycosis 9/17/2014 9:38:34 AM
1234567
//-->